Cannabis is the most commonly used illicit drug worldwide, with~ 5 million daily users
worldwide. Emerging evidence supports a number of associations between cannabis and …

Rationale Cannabis abuse and endocannabinoids are associated to schizophrenia.
Objectives It is important to discern the association between schizophrenia and exogenous …

We review the use of neural field models for modelling the brain at the large scales
necessary for interpreting EEG, fMRI, MEG and optical imaging data. Albeit a framework that …

Recent advances in knowledge about cannabinoid receptor function have renewed interest
in the association between cannabis and psychosis. Converging lines of evidence suggest …

The current treatment of Parkinson's disease with dopamine-centric approaches such as l-
DOPA and dopamine agonists, although very successful, is in need of alternative treatment …

The evidence for an environmental component in chronic psychotic disorders is strong and
research on the epigenetic manifestations of these environmental impacts has commenced …

Cannabis use has been associated with altered sensory gating and neural oscillations.
However, it is unclear which constituent in cannabis is responsible for these effects, or …

Drug use and abuse continues to thrive in contemporary society worldwide and the instance
and damage caused by addiction increases along with availability. The Effects of Drug …

Sensory gating, a mandatory process in early information processing, has been found to be
defective in neuropsychiatric diseases such as schizophrenia. Understanding the …

Rationale Given the hypothesised association between cannabis use and schizophrenia,
and the well documented alterations in pre-pulse inhibition (PPI) that are observed in …